Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MET oncogene inhibition as a potential target of therapy for uveal melanomas.

Investigative ophthalmology & visual science - 1 Jul 2010

Abdel-Rahman Mohamed H, Boru Getachew, Massengill James, Salem Manar M, Davidorf Frederick H

Abstract excerpt

PURPOSE. The purposes of this study were to investigate the frequency of MET activation in uveal melanomas (UMs), to study the potential molecular mechanism for its activation, and to assess the utility of MET inhibition as a potential therapy for UM. METHODS. The frequency of MET activation in U...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Indoles
Share to Piperazines
Share to Proto-Oncogene Proteins c-met

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Receptor Protein-Tyrosine Kinases

Share to Receptors, Growth Factor

Share to Sulfonamides

Share to Transcriptional Activation

Share to Uveal Neoplasms

Source

Identifiers

PMID: 20164465
DOI: 10.1167/iovs.09-4801

Genes

MET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20164465-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MET oncogene inhibition as a potential target of therapy for uveal melanomas.PMID 20164465Read ↗

Targeting MET Dysregulation in CancerSemantic proximity Read ↗

PTK2 Promotes Uveal Melanoma Metastasis by Activating Epithelial-to-Mesenchymal TransitionSemantic proximity Read ↗

c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potentialSemantic proximity Read ↗

MET receptor tyrosine kinase as a therapeutic anticancer target.Semantic proximity Read ↗

MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanomaSemantic proximity Read ↗

Simultaneous inhibition of the HGF/MET and Erk1/2 pathways affect uveal melanoma cell growth and migration.Semantic proximity Read ↗

Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stromaSemantic proximity Read ↗

Imatinib targeting of KIT-mutant oncoprotein in melanoma.Semantic proximity Read ↗

Oncogenic role of microRNA‑20a in human uveal melanoma.Semantic proximity Read ↗

MicroRNA-34a Inhibits Uveal Melanoma Cell Proliferation and Migration through Downregulation of c-MetSemantic proximity Read ↗

Association of activated c-Met with NRAS-mutated human melanomas.Semantic proximity Read ↗

Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.